top of page

Among 2019 top 10 Biotech IPOs, 5 reached more than 1 $Bn valuation

  • Writer: Laurent DECORY
    Laurent DECORY
  • Feb 25, 2020
  • 1 min read

Updated: Mar 24, 2020

Among 2019 top 10 Biotech IPOs Genmab's $505 million came #1, while BridgeBio Pharma, Gossamer Bio, Alector and BioNTech also joined the billion-plus valuation club.


Half of top IPOs were cancer-focussed, followed by genetic diseases.


2020 forecast remains uncertain, for now.





Comentarios


bottom of page